2590
N.V. Loginova et al. / Polyhedron 30 (2011) 2581–2591
Table 7
4. Conclusions
Effect of electron-transfer proteins of P450-dependent monooxygenase systems on
the rate of Cyt c (7
l
mol lꢀ1) reduction (
m
) with HLI and HLII ligands (35
l
mol lꢀ1).
The complexes Cu(LI)2, Mn(LI)2 and Co(LII)2 with the high reduc-
ing ability (determined electrochemically) were found to be char-
acterized by the highest rates of Cyt c reduction. As a whole, the
reduction of Cyt c by the ligands and their metal complexes may
not be related solely to the facility of their oxidation, as it is possi-
ble that ionization of the compounds exerts a noticeable effect on
this process, too. The antibacterial activity of these compounds was
found to follow the order: (1) Cu(LI)2 > Mn(LI)2 > HLI > Ni(LI)2 >
Ligand
Enzyme/concentration (nmol lꢀ1
)
m
(nmol minꢀ1
)
HLI
HLI
HLI
HLII
HLII
HLII
0.9 0.1
0.8 0.1
0.9 0.1
P450R/170
P450R/270
1.0 0.1
0.9 0.1
0.9 0.1
P450R/170
P450R/270
Zn(LI)2 > Fe(LI)2 > Co(H2O)2LI;
(2)
Cu(LII)2 > Co(LII)2 > Ni(LII)2 >
Mn(H2O)2(LII)2 > Fe(LII)2 > HLII > Zn(LII)2; their reducing ability
(determined electrochemically) followed the same order. These se-
quences are not entirely the same as those characterizing the de-
crease of the rates of Cyt c reduction with the ligands and their
metal complexes. Despite the fact that in individual cases we have
found a correlation between the rates of Cyt c reduction and phys-
ico-chemical characteristics of the compounds under study, the
ability of bioactive compounds to interact with biomolecules has
a more intricate dependence on the structure and physico-chemi-
cal properties thereof.
Table 8
Calculated parameters for docked conformations of the ligands to P450R.
Ligand Lateral
groups
Lmin(O–N) (Å)/Kint
Kint range
(mmol lꢀ1
)
(mmol lꢀ1
)
HLI
–CO2H
–CO2H
–CH2OH
–CH3
3.1/86.9
6.4/63.3
3.5/1.4
2.9/5.2
17.7–147.6
14.1–152.3
1.4–14.2
HLII
HLIV
HLV
2.6–7.1
by the highest Cyt c reduction rate, thus being one of the strongest
reducing agents in this series of complexes. Cu(LII)2 complex, in
spite of the most cathodic ðEap1 þ Epc1Þ=2 value among these com-
pounds, ranks below Co(LII)2 complex in the rate of Cyt c reduction
(Table 6), which may be due to its being more stable to dissociation
as compared to the above-mentioned complexes. The rate of Cyt c
reduction with the rest of the metal complexes with the ligand HLII
varies in a very narrow range (2–3 nmol minꢀ1) and does not cor-
relate with their reducing ability determined electrochemically
(Tables 3 and 6).
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
References
[1] N.V. Loginova, T.V. Koval’chuk, R.A. Zheldakova, A.A. Chernyavskaya, N.P.
Osipovich, G.K. Glushonok, G.I. Polozov, V.L. Sorokin, O.I. Shadyro, Centr. Eur. J.
Chem. 4 (2006) 440.
[2] T.V. Koval’chuk, N.V. Loginova, G.I. Polozov, A.A. Chernyavskaya, D.A. Gursky,
O.I. Shadyro, Vestnik BGU. Ser. 2. Khim., Biol. Geogr. (2) (2008) 25 (in Russian).
[3] N.V. Loginova, T.V. Koval’chuk, R.A. Zheldakova, A.A. Chernyavskaya, N.P.
Osipovich, G.K. Glushonok, G.I. Polozov, V.N. Povalishev, V.L. Sorokin, O.I.
Shadyro, Polyhedron 25 (2006) 3603.
[4] N.V. Loginova, T.V. Koval’chuk, R.A. Zheldakova, N.P. Osipovich, V.L. Sorokin,
G.I. Polozov, G.A. Ksendzova, G.K. Glushonok, A.A. Chernyavskaya, O.I. Shadyro,
Bioorg. Med. Chem. Lett. 16 (2006) 5403.
[5] N.V. Loginova, T.V. Koval’chuk, N.P. Osipovich, G.I. Polozov, V.L. Sorokin, A.A.
Chernyavskaya, O.I. Shadyro, Polyhedron 27 (2008) 985.
[6] N.V. Loginova, T.V. Koval’chuk, G.I. Polozov, N.P. Osipovich, P.G. Rytik, I.I.
Kucherov, A.A. Chernyavskaya, V.L. Sorokin, O.I. Shadyro, Eur. J. Med. Chem. 43
(2008) 1536.
[7] N.V. Loginova, Y.V. Faletrov, T.V. Koval’chuk, N.P. Osipovich, G.I. Polozov, A.A.
Chernyavskaya, R.A. Zheldakova, I.I. Azarko, A.T. Gres’, O.I. Shadyro, V.M.
Shkumatov, Polyhedron 29 (2010) 1646.
[8] A. Albert, Selective Toxicity: Physico-Chemical Basis of Therapy, Chapman and
Hall, London, New York, 1985.
[9] S. Bollo, L.J. Núñez-Vergara, S. Kang, L. Zhang, H.I. Boshoff, C.E. Barry III, J.A.
Squella, C.S. Dowd, Bioorg. Med. Chem. Lett. 21 (2011) 812.
The influence of P450R on the rate of Cyt c reduction with HLI
and HLII ligands was studied. The addition of P450R had essentially
no effect on the initial rate of Cyt c reduction with the compounds
under study (Table 7), as opposed to the phenolic ligands 4,6-di(-
tert-butyl)-3[(2-ethyl)sulfanyl]-1,2-dihydroxybenzene (HLIV) and
2-amino-4,6-di(tert-butyl)phenol studied before [7]. This is indica-
tive of o-diphenol derivatives of thioglycolic acid being incapable
of redox interactions with P450R, responsible for an increase of
Cyt c reduction in vitro in the system described. In this connection
we have studied Cyt c reduction and P450R affecting this process
with the participation of a structural analog of o-diphenol deriva-
tives of thioglycolic acid, 4,6-di(tert-butyl)-3-ethylsulfanyl-1,2-
dihydroxybenzene (HLV), containing a lateral methyl group instead
of a carboxylic one. The rate of Cyt c reduction with this compound
was found to be 0.7 0.1 nmol Cyt c ꢂ minꢀ1, and it is about twice
as high as that with P450R added. Analyzing structure-functional
differences of these ligands, we can reveal probable reasons for this
effect: (i) a smaller reductive ability of the ligands HLI and HLII
compared to the o-diphenol and o-aminophenol derivatives stud-
ied before [7], (ii) lateral carboxylic groups of HLI and HLII ligands
being negatively charged at physiological pH 7.4.
It should be mentioned that redox-active FMN edge in P450R is
surrounded by several negatively charged residues of Glu and Asp
amino acids located on the protein surface. To evaluate the sup-
posed contribution of electrostatic repulsion into P450R interac-
tion with the ligands under study, we carried out docking
experiments of the above-mentioned ligand structures in the ac-
tive center of P450R according to the procedure described in
[33–35]. Millimolar order of Kint values calculated from the docking
results suggests the non-specific character of P450R interaction
with all the compounds described above, but the compounds HLIV
and HLV were more effectively bound in the vicinity of FMN than o-
diphenol derivatives of thioglycolic acid HLI and HLII under in silico
conditions (Table 8).
[10] B. Wen, K.J. Coe, P. Rademacher, W.L. Fitch, M. Monshouwer, S.D. Nelson,
Chem. Res. Toxicol. 21 (2008) 2393.
[11] J. Simon, FEMS Microbiol. Rev. 26 (2002) 285.
[12] J. Hendriks, A. Oubrie, J. Castresana, A. Urbani, S. Gemeinhardt, M. Saraste,
Biochim. Biophys. Acta 1459 (2000) 266.
[13] L. De Smet, S.N. Savvides, E. Van Horen, G. Pettigrew, J.J. Van Beeumen, J. Biol.
Chem. 281 (2006) 4371.
[14] I. Bertini, G. Cavallaro, A. Rosato, Chem. Rev. 106 (2006) 90.
[15] L. Thony-Meyer, Microbiol. Mol. Biol. Rev. 61 (1997) 337.
[16] N.V. Loginova, T.V. Koval’chuk, G.I. Polozov, N.P. Osipovich, A.A.
Chernyavskaya, V.L. Sorokin, O.I. Shadyro, Redox-active antimicrobial metal
complexes with sterically hindered o-diphenol and o-aminophenol
derivatives, in: G. Blanc, D. Moreau (Eds.), Biometals: Molecular Structures,
Binding Properties, Nova Science Publisher’s, Hauppauge, New York, 2010, pp.
59–90.
[17] M. Buhl, H. Kabrede, J. Chem. Theory Comput. 2 (2006) 1282.
[18] T. Wang, G. Brudvig, V.S. Batista, J. Chem. Theory Comput. 6 (2010) 755.
[19] Y. Yang, M.N. Weaver, K.M. Merz, J. Phys. Chem. A 113 (2009) 9843.
[20] Z. An, J. Zhang, R. Wang, N. Koga, Polyhedron 26 (2007) 2126.
[21] K. Malek, H. Kozlowski, L.M. Proniewicz, Polyhedron 24 (2005) 1175.
[22] A. Leo, C. Hansch, D. Elkins, Chem. Rev. 71 (1971) 525.
[23] M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman,
J.A. Montgomery Jr., T. Vreven, K.N. Kudin, J.C. Burant, J.M. Millam, S.S. Iyengar,
J. Tomasi, V. Barone, B. Mennucci, M. Cossi, G. Scalmani, N. Rega, G.A.
Petersson, H. Nakatsuji, M. Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa,